Page last updated: 2024-11-03

prazosin and Preterm Birth

prazosin has been researched along with Preterm Birth in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Research Excerpts

ExcerptRelevanceReference
"Subjects were 11 patients who took prazosin during pregnancy and were counselled at the FRAME clinic in London Health Sciences Centre (Ontario, Canada) between 1 January 2000 and 31 December 2021."8.31Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin. ( Campbell, MK; Garcia-Bournissen, F; Matsui, D; Zitoun, N, 2023)
"Subjects were 11 patients who took prazosin during pregnancy and were counselled at the FRAME clinic in London Health Sciences Centre (Ontario, Canada) between 1 January 2000 and 31 December 2021."4.31Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin. ( Campbell, MK; Garcia-Bournissen, F; Matsui, D; Zitoun, N, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zitoun, N1
Campbell, MK1
Matsui, D1
Garcia-Bournissen, F1

Other Studies

1 other study available for prazosin and Preterm Birth

ArticleYear
Prospective evaluation of pregnancy outcomes after gestational exposure to prazosin.
    British journal of clinical pharmacology, 2023, Volume: 89, Issue:11

    Topics: Female; Humans; Infant, Newborn; London; Ontario; Prazosin; Pregnancy; Pregnancy Outcome; Premature

2023